Gate Neurosciences emerges from stealth to tackle CNS diseases
Gate Neurosciences has officially launched to develop its next-generation therapeutics addressing synaptic dysfunction in patients…
August 23, 2022 - 3 minutes
AbbVie
Formulations of Arecor Therapeutics’ drug to treat inflammatory diseases granted patents
Formulations of a drug that can help a number of inflammatory diseases including rheumatoid arthritis…
August 9, 2022 - 3 minutes
Sosei Heptares and AbbVie enter second collaboration targeting neurological diseases
A new drug discovery collaboration has taken place between Japanese Sosei Group Corporation and UK-based…
August 2, 2022 - 2 minutes
Positive results for drug combination used to treat rare blood cancer
Exploratory analysis of anti-cancer drug, navitoclax, combined with ruxolitinib - a medication for the treatment…
July 18, 2022 - 3 minutes
French Juvisé buys gastro product in €400M finance deal
French pharmaceutical company, Juvisé has just bought worldwide commercial rights to Pylera from US biopharmaceutical…
July 7, 2022 - 2 minutes
AbbVie and Genmab Strike €3.4B Immuno-Oncology Megadeal
AbbVie and Genmab have announced a €3.4B collaboration deal that ranks as the second biggest…
June 11, 2020 - 3 minutes
AbbVie Enters Industry Collaboration to Fight Alzheimer’s and Parkinson’s Disease
The UK biotech Mission Therapeutics has teamed up with AbbVie to develop new drugs to…
November 16, 2018 - 2 minutes
French Biotech Lures Big Pharma with Fibrosis Treatments
This week, Inventiva has received a milestone payment from Boehringer Ingelheim and extended its collaboration with…
September 5, 2017 - 1 minute
Next-Gen Cancer Antibody Technology from Germany enters the Clinic
Apogenix' partner AbbVie has started the first clinical trial for an immuno-oncology candidate with the…
April 13, 2017 - 2 minutes
Galapagos Enters Clinical Trials with New Cystic Fibrosis Drug
Galapagos has announced to kick off a Phase I trial with its novel Cystic Fibrosis…
March 23, 2017 - 2 minutes
Galapagos kicks off a Phase IIa trial for Cystic Fibrosis
After Galapagos and AbbVie expanded their collaboration on cystic fibrosis, Galapagos now announces the start…
February 2, 2017 - 2 minutes
One Step Closer to the First Triple Combination Therapy for Cystic Fibrosis
Galapagos and AbbVie are closer to launching a cystic fibrosis treatment that can outperform the…
November 29, 2016 - 2 minutes
